A novel human liver-chimeric mouse model developed at Oregon Health & Science University and Yecuris Corporation has made possible a research breakthrough at Seattle Biomedical Research Institute that will greatly accelerate studies of the most lethal forms of human malaria. The study findings...
"ACTEMRA®" Humanized Anti-Human IL-6 Receptor Monoclonal Antibody Conditions For Appr
Chugai Pharmaceutical Co., Ltd. announced today that it has received a notification from the Japanese Ministry of Health, Labour and Welfare (MHLW) that the conditions for approval (surveillance of all...